Internal restructuring
Location of affected unit(s)
Marly-le-Roi (Yvelines), Evreux, Mayenne, France
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.1 - Manufacture of basic pharmaceutical products

271 jobs
Number of planned job losses
Job loss
49 jobs
Number of planned job creations
Job creation
Announcement Date
22 October 2013
Employment effect (start)
1 January 2014
Foreseen end date


Pharmaceutical group Glaxo Smith Kline (GSK) is to reduce its workforce by 271 and to create 49 positions in France.

GSK announced to cut 89 positions iat its headquarters in Marly-le-Roy, 11 in its plant of Evreux, 3 in plant in Mayenne and 78 positions of medical representatives. The remaining 90 cuts are to be implemented by non-replacement of already vacant positions.

Furthermore, the group is to recruit 49 employees.

The restructuring takes place as part of a European-wide plan announced last February.

GSK employs 3,442 staff in France. In 2009, the company had already announced to cut 1184 staff in France.


  • 21 October 2013: Le Figaro
  • 22 October 2013: Les Echos
  • 21 October 2013: Usine Nouvelle


Eurofound (2013), Glaxo Smith Kline, Internal restructuring in France, factsheet number 76029, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/76029.